Juniper Advisory Adds George Brown as a Senior Advisor
SEATTLE, WA / ACCESSWIRE / May 24, 2022 / Juniper Advisory announced that Dr. George Brown joined the firm as...
Day: May 24, 2022
The United States Pharmacovigilance Market Size is Expected to Reach USD 3,109.03 Million by 2027 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance Market Research Report by Type (Contract Outsourcing and In-house), Clinical Trial, Method, End User, State - United...
The Healthcare Technology Report Names Andrea Kowalski on List of Top 25 Women in Healthcare IT in 2022
SVP of Product Recognized for Contributions to Provider and Patient Outcomes IRVINE, Calif.--(BUSINESS WIRE)--#EHR--Tebra, a leader in practice growth technology...
Mobile Heartbeat Announces Integration Partnership to Decrease Clinician Reaction Time
Clinical Collaboration Provider Integrates with Stryker’s iBed Wireless System to Decrease Clinician Reaction Time During Bed Events WALTHAM, Mass.--(BUSINESS WIRE)--#clinicalcomms--Leading...
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences’ CEO Richard T. Schumacher
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced...
Predictmedix to Present at 12th Annual LD Micro Invitational
Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022TORONTO, ON / ACCESSWIRE / May...
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children resulting in significant...
Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board
Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board Castellum, Inc. (OTC: ONOV) announces that former Virginia...
Ogilvy Health Builds Upon Leadership Team With Courtney Murphy Joining the Agency as Global People Director
Courtney Murphy Global People DirectorNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Ogilvy Health today announced industry veteran, Courtney Murphy,...
Progyny Lands Employer Benefits Expert in Expansion of Leadership Team
Arielle Bogorad joins Progyny as Senior Vice President of Employer Market StrategyNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Progyny,...
Signati™ Medical, Inc. Debuts Innovative Bipolar Radio Frequency Sealing Platform at American Urological Association (AUA) Annual Meeting
Providence, RI, May 24, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. is pleased to announce the unveiling of their innovative...
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international...
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment
Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption TEL AVIV, Israel, May 24, 2022...
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports
HENDERSON, Nev., May 24, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered...
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity
SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage...
Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance Botensilimab
Data to be Presented in Heavily Pretreated MSS-CRCSpeed and Innovation Core to Development StrategyReduction of 20% in 2022 Operating CostsLEXINGTON,...
Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital...
Clearmind Medicine and SciSparc Collaboration Yields Positive Results for its Psychedelic Combination Treatment
Pre-clinical trial based on the proprietary combination demonstrates high safety profile in addition to a significant suppressive effect on alcohol...
TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense
DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as...
Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference
OXFORD, United Kingdom, May 24, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics...